Vimarsana
Biggest News Aggregation in the World

Marc Bonaca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marc Bonaca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marc Bonaca Today - Breaking & Trending Today

Early Win for Preemptive Stents on Vulnerable Coronary Plaque - Vimarsana News

Early Win for Preemptive Stents on Vulnerable Coronary Plaque

Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial

PAD, AAA: High Lp(a) Portends Problems Beyond CVD - Vimarsana News

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

While the field awaits targeted therapies, estimates of absolute 10-year risks can be used to counsel patients, researchers say.

Source: tctmd.com
TRANSFORM Trial Unveiled: AI-Powered Approach for Personalized Heart Disease Care - Vimarsana News

TRANSFORM Trial Unveiled: AI-Powered Approach for Personalized Heart Disease Care

Cleerly and partners embark on the groundbreaking TRANSFORM trial, harnessing AI's power to personalize heart disease care and....

Experts' Perspectives: Top News in Cardiology for 2023 - Vimarsana News

Experts' Perspectives: Top News in Cardiology for 2023

A group of 13 leading experts provides their perspectives on the top news in cardiovascular medicine from 2023, with responses ranging from novel approvals to new semaglutide data to gene therapy and more.

Rivaroxaban Demonstrates Favorable Benefit-Risk Profile in Fragile Populations with Peripheral Arterial Disease - Vimarsana News

Rivaroxaban Demonstrates Favorable Benefit-Risk Profile in Fragile Populations with Peripheral Arterial Disease

Bonaca also notes that pharmacists can play a key role in educating patients and clinicians about the appropriate use and dosing of antithrombotic drugs for vascular protection.